TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial.

Julie M Vose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.